Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Sell Aptamer Group (APTA) by Steve Moore in ShareProphets
- Sell Windar Photonics (WPHO) by Steve Moore in ShareProphets
- Avoid URU Metals Ltd. (DI) (URU) by Nigel Somerville in ShareProphets
- Sell Videndum (VID) by Steve Moore in ShareProphets
- Avoid PZ Cussons (PZC) by Steve Moore in ShareProphets
- Avoid TT Electronics (TTG) by Steve Moore in ShareProphets
- Sell Microsaic Systems (MSYS) by Steve Moore in ShareProphets
- Sell The Revel Collective (TRC) by Steve Moore in ShareProphets
- Buy KEFI Gold and Copper (KEFI) by Hot Stock Rockets in ShareProphets
- Avoid Naked Wines (WINE) by Steve Moore in ShareProphets
- Sell Mirriad Advertising (MIRI) by Steve Moore in ShareProphets
- Hold M&G (MNG) by Cliff D'Arcy in The Motley Fool
- Buy Safestore Holdings (SAFE) by Zaven Boyrazian in The Motley Fool
- Buy Altona Rare Earths (REE) by Hot Stock Rockets in ShareProphets
- Avoid Surgical Innovations Group (SUN) by Steve Moore in ShareProphets
- Outperform OSB Group (OSB) by RBC Capital
- Buy Diageo (DGE) by Harvey Jones in The Motley Fool
- Watch Nexteq (NXQ) by Steve Moore in ShareProphets
- Overweight Jet2 (JET2) by Barclays
- Outperform IntegraFin Holding (IHP) by RBC Capital
Avacta Group (AVCT) Share Price
Health Care Sector
NOTE: This is based on 63 open tips for Avacta Group (AVCT)
| Latest Bid : 52.00p | Latest Ask : 53.00p |
| High Today : 57.60p | Low Today : 49.50p |
| This Years High : 82.50p | This Years Low : 27.50p |
| Volume : 5,711,385 | MKT Cap : £193.73M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
26/01/2016 – Stock Consolidation 100.000:1.000
Avacta Group (AVCT) Overview
Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION platforms.Avacta Group (AVCT) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Peel Hunt | Premium Only | 2025-09-30 11:17:00 30/09/2025 | -2.78% |
| Sell | Tom Winnifrith | Premium Only | 2025-02-18 10:55:00 18/02/2025 | -32.91% |
| Sell | Lucian Miers | Premium Only | 2024-12-27 10:05:00 27/12/2024 | -9.38% |
| Sell | Tom Winnifrith | Premium Only | 2024-12-12 13:30:00 12/12/2024 | -22.09% |
| Hold | Deutsche Bank | Premium Only | 2024-12-10 07:30:00 10/12/2024 | 16.02% |
Avacta Group (AVCT) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 52.00p | Latest Ask : 53.00p |
| High Today : 57.60p | Low Today : 49.50p |
| This Years High : 82.50p | This Years Low : 27.50p |
| Volume : 5,711,385 | MKT Cap : £193.73M |
Avacta Group Overview
Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION platforms.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Avacta Group Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Peel Hunt | Premium Only | 2025-09-30 11:17:00 30/09/2025 | -2.78% |
| Sell | Tom Winnifrith | Premium Only | 2025-02-18 10:55:00 18/02/2025 | -32.91% |
| Sell | Lucian Miers | Premium Only | 2024-12-27 10:05:00 27/12/2024 | -9.38% |
| Sell | Tom Winnifrith | Premium Only | 2024-12-12 13:30:00 12/12/2024 | -22.09% |
| Hold | Deutsche Bank | Premium Only | 2024-12-10 07:30:00 10/12/2024 | 16.02% |
Stock Splits and Consolidations
26/01/2016 – Stock Consolidation 100.000:1.000